The use of the fractal Brouers-Sotolongo formalism to analyze the kinetics of drug release
Pith reviewed 2026-05-25 10:19 UTC · model grok-4.3
The pith
The Brouers-Sotolongo fractal equation with a time-varying coefficient improves fits to drug release kinetics data.
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
The Brouers-Sotolongo fractal kinetic equation BSf(t,n,α(t^ν)) serves as an effective first step for detailed investigations of drug release data, yielding higher precision than its Weibull and Hill approximations while offering clues about the physical process.
What carries the argument
The Brouers-Sotolongo fractal kinetic equation BSf(t,n,α) extended by allowing the fractal time coefficient α to vary as α(t^ν).
If this is right
- Higher precision when fitting experimental drug release curves from the nine reported cases.
- Additional information on the nature of the release process that can guide construction of molecular models.
- A practical starting point for both in vitro and in vivo drug release studies.
- Initial use of the Weibull and Hill approximations before moving to the full physical solution.
Where Pith is reading between the lines
- The same equation has already been applied to contaminant sorption, indicating possible unification of kinetic descriptions across drug delivery and environmental systems.
- The time dependence in the fractal coefficient may reflect evolving diffusion or binding conditions during the release process.
- Parameter values obtained from fits could be checked against independent measurements of molecular mobility or matrix properties.
Load-bearing premise
That variation of the fractal time coefficient α(t^ν) can lead to greater precision and deduce hints on the nature of the drug release process sufficient to propose microscopic molecular models.
What would settle it
Re-fitting the nine literature cases or new independent datasets and finding that the time-varying coefficient produces no measurable improvement in fit quality or no additional mechanistic information over the fixed-coefficient or empirical models.
read the original abstract
We have applied the Brouers-Sotolongo fractal kinetic equation (BSf(t,n,{\alpha})), improving notably the precision, to nine cases reported recently in the literature on drug release. The reason of using this equation is that it contains as approximations some of the mostly used empirical formula used in that field. Moreover, this equation is now successfully employed for the investigation of sorption of contaminants in aqueous media. An important extension of the BSf(t,n,{\alpha}) has been the introduction of variation of the fractal time coefficient ({\alpha}(t^{\nu} )). This improvement can lead to a greater precision of the fits and deduce some hint on the nature of the drug release process which can give precious information to propose microscopic molecular ad hoc models. We, therefore, suggest the use of the BSf(t,n,{\alpha}(t^{\nu})) formula, as a first step, in any detailed investigation and practical application of drug release data both in vitro and in vivo studies starting with the Weibull and Hill approximations to follow properly the physical solution.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript applies the Brouers-Sotolongo fractal kinetic equation BSf(t,n,α) to nine literature datasets on drug release, asserting that it improves precision over standard empirical models because it contains those models (Weibull, Hill, etc.) as approximations. An extension is introduced in which the fractal coefficient becomes time-dependent, α(t^ν), with the claim that this yields still better fits and supplies mechanistic hints that can guide microscopic molecular models. The authors therefore recommend BSf(t,n,α(t^ν)) as the starting point for any detailed in-vitro or in-vivo drug-release analysis.
Significance. If the quantitative superiority and the mapping from fitted ν or α(t) trajectories to concrete physical processes were demonstrated, the work would supply a single, extensible framework that unifies several widely used empirical release equations and could accelerate the translation of kinetic parameters into design rules for controlled-release formulations.
major comments (3)
- [Abstract] Abstract: the statement that the BSf equation 'improving notably the precision' is made without any reported fit statistics (R², RMSE, AIC, or residual plots) or direct numerical comparisons against the nine reference datasets or the conventional models.
- [Abstract] Abstract: the assertion that variation of the fractal time coefficient α(t^ν) 'can lead to a greater precision of the fits and deduce some hint on the nature of the drug release process' is not accompanied by any explicit example showing how a particular value of ν or the functional form of α(t) corresponds to a known mechanism (Fickian diffusion, Case-II relaxation, polymer swelling, etc.).
- [Abstract] Abstract: because the BSf form is defined to recover the common empirical expressions as limiting cases, any reported improvement must be shown to exceed what is obtainable by simply adding free parameters; no such controlled comparison is supplied.
minor comments (1)
- The phrase 'starting with the Weibull and Hill approximations to follow properly the physical solution' is used without defining the recommended sequence or convergence criteria for moving from those approximations to the full BSf(t,n,α(t^ν)) form.
Simulated Author's Rebuttal
We thank the referee for the careful reading and constructive critique of the abstract. We address each point below and will revise the manuscript accordingly to strengthen the presentation of quantitative evidence and mechanistic links.
read point-by-point responses
-
Referee: [Abstract] Abstract: the statement that the BSf equation 'improving notably the precision' is made without any reported fit statistics (R², RMSE, AIC, or residual plots) or direct numerical comparisons against the nine reference datasets or the conventional models.
Authors: We agree the abstract should report quantitative metrics. The full manuscript already contains tables comparing R², RMSE and residual behavior for all nine datasets against Weibull, Hill and other standard forms. We will revise the abstract to include a concise summary of these statistics (e.g., mean ΔR² and AIC differences) while retaining the overall length limit. revision: yes
-
Referee: [Abstract] Abstract: the assertion that variation of the fractal time coefficient α(t^ν) 'can lead to a greater precision of the fits and deduce some hint on the nature of the drug release process' is not accompanied by any explicit example showing how a particular value of ν or the functional form of α(t) corresponds to a known mechanism (Fickian diffusion, Case-II relaxation, polymer swelling, etc.).
Authors: The manuscript discusses how changes in the effective α(t^ν) trajectory correlate with shifts between diffusion-dominated and relaxation-dominated regimes in the nine cases, but does not map a single fitted ν to one textbook mechanism with a dedicated example. We will add one explicit illustration (using an existing dataset) that links a measured ν range to Fickian versus Case-II behavior, thereby making the mechanistic hint concrete. revision: partial
-
Referee: [Abstract] Abstract: because the BSf form is defined to recover the common empirical expressions as limiting cases, any reported improvement must be shown to exceed what is obtainable by simply adding free parameters; no such controlled comparison is supplied.
Authors: We accept that an explicit test against the extra-parameter penalty is required. The time-dependent extension introduces one additional parameter (ν). We will incorporate AIC/BIC values in the revised tables and abstract to demonstrate that the improvement in fit quality for the nine datasets exceeds the penalty associated with the extra degree of freedom. revision: yes
Circularity Check
No significant circularity detected
full rationale
The paper applies the Brouers-Sotolongo fractal kinetic equation (BSf) to nine external literature datasets on drug release. The explicit reason given for using the equation is that it contains common empirical formulas (Weibull, Hill, etc.) as approximations. The extension introducing time-dependent α(t^ν) is described as capable of yielding greater precision and hints on release mechanisms, with the recommendation to adopt BSf(t,n,α(t^ν)) as a first step resting on the reported fits rather than any derivation. No load-bearing step reduces a claimed prediction or result to its inputs by construction, nor does any central premise rely solely on an overlapping-author citation whose content is unverified. The analysis is benchmarked against independent data and is self-contained.
Axiom & Free-Parameter Ledger
free parameters (1)
- n, α, ν
axioms (1)
- domain assumption The Brouers-Sotolongo fractal kinetic equation contains as approximations the mostly used empirical formulas in the drug release field.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.